Results 251 to 260 of about 175,837 (263)

Anti-PD-1 therapies—a new first-line option in advanced melanoma

Nature Reviews Clinical Oncology, 2015
Ryan Sullivan, Keith Flaherty, Sullivan Ryan J   +2 more
exaly  

The Changing Kinetics of Advanced Melanoma

JAMA Dermatology, 2019
openaire   +2 more sources

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Annals of Oncology, 2014
Bart Neyns, J D Wolchok, M B Mchenry
exaly  

Reality check for nivolumab in advanced-stage melanoma

Nature Reviews Clinical Oncology, 2017
Diana Romero, Romero Diana
exaly  

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Lancet, The, 2014
Anthony Joshua, Richard Joseph, Richard Kefford   +2 more
exaly  

The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs

Ca-A Cancer Journal for Clinicians, 2010
Darrell S Rigel
exaly  

Malignant melanoma: prevention, early detection, and treatment in the 21st century

Ca-A Cancer Journal for Clinicians, 2000
Darrell S Rigel
exaly  

Nivolumab and Ipilimumab in Advanced Melanoma

New England Journal of Medicine, 2017
Wolchok, JD, Rollin, L, Larkin, J
openaire   +5 more sources

Advances in melanocyte and melanoma biology

Archives of Biochemistry and Biophysics, 2014
Hasan, Mukhtar, Vijayasaradhi, Setaluri
openaire   +2 more sources

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma

Nature Reviews Clinical Oncology
John Haanen, Tom Seijkens, Ton Schumacher   +2 more
exaly